Quantitative biodistribution studies have shown that those radiolabeled immunocytokines directed against the EDB domain of fibronectin preferentially localize to the tumor without being trapped in blood or secondary lymphoid organs (Erba et al, 2012; Poli et al, 2013). This evidence concerns the gene FN1 and neoplasm.